Literature DB >> 24412300

Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella.

Andrea Streng1, Johannes G Liese2.   

Abstract

BACKGROUND: Germany introduced routine varicella (V) vaccination in 2004. Due to a slightly increased risk of febrile convulsions after first-dose application of combined measles-mumps-rubella-varicella (MMRV) vaccine separate first-dose vaccinations with MMR and monovalent V vaccine were recommended in September 2011.
METHODS: We compared V and MMR vaccinations in paediatric practices from two surveillance regions (Munich and Würzburg) one year before and after the change in the recommendation.
RESULTS: A total of 1405/326 monthly reports were provided by a monthly average of 79/14 practices participating in Munich/Würzburg. V first-dose vaccinations (monovalent V or MMRV vaccine) declined by 12% in Munich (from 10.1 to 8.9 vaccinations per month and practice; p<0.005) and by 4% in Würzburg (from 9.9 to 9.5; p=0.620), respectively. First-dose vaccinations for MMR (MMR or MMRV vaccine) did not change significantly in both regions.
CONCLUSION: Acceptance of V vaccination depends in part on the use of combination vaccine.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Surveillance; Vaccination; Varicella

Mesh:

Substances:

Year:  2014        PMID: 24412300     DOI: 10.1016/j.vaccine.2013.12.065

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  A postmarket safety comparison of 2 vaccination strategies for measles, mumps, rubella and varicella in Italy.

Authors:  Silvia Cocchio; Giovanna Zanoni; Roberta Opri; Francesca Russo; Vincenzo Baldo
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.

Authors:  Silvio Tafuri; Francesca Fortunato; Maria Giovanna Cappelli; Vanessa Cozza; Angela Bechini; Paolo Bonanni; Domenico Martinelli; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia.

Authors:  Kristine Macartney; Heather F Gidding; Lieu Trinh; Han Wang; Aditi Dey; Brynley Hull; Karen Orr; Jocelynne McRae; Peter Richmond; Michael Gold; Nigel Crawford; Jennifer A Kynaston; Peter McIntyre; Nicholas Wood
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 16.193

4.  Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.

Authors:  Shannon E MacDonald; Douglas C Dover; Kimberley A Simmonds; Lawrence W Svenson
Journal:  CMAJ       Date:  2014-06-09       Impact factor: 8.262

Review 5.  Issues in pediatric vaccine-preventable diseases in low- to middle-income countries.

Authors:  Ghassan Dbaibo; Vladimir Tatochenko; Peter Wutzler
Journal:  Hum Vaccin Immunother       Date:  2016-06-20       Impact factor: 3.452

6.  Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance.

Authors:  Christine Hagemann; Andrea Streng; Alexander Kraemer; Johannes G Liese
Journal:  BMC Public Health       Date:  2017-09-19       Impact factor: 3.295

7.  Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.

Authors:  Katsiaryna Holl; Christophe Sauboin; Emanuele Amodio; Paolo Bonanni; Giovanni Gabutti
Journal:  BMC Public Health       Date:  2016-10-21       Impact factor: 3.295

Review 8.  Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.

Authors:  Andrea-Ioana Beleni; Stefan Borgmann
Journal:  Int J Environ Res Public Health       Date:  2018-07-31       Impact factor: 3.390

9.  Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.

Authors:  Vincent Bauchau; Lionel Van Holle; Carine Cohen
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606

10.  Specific Varicella-Related Complications and Their Decrease in Hospitalized Children after the Introduction of General Varicella Vaccination: Results from a Multicenter Pediatric Hospital Surveillance Study in Bavaria (Germany).

Authors:  Christine Hagemann; Alexander Krämer; Veit Grote; Johannes G Liese; Andrea Streng
Journal:  Infect Dis Ther       Date:  2019-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.